People Make The Difference

Allergan Pharmaceuticals is led by a team of skilled pharmaceutical veterans, many of whom have experience as healthcare practitioners. Our people fully understand the pharmaceutical development process and the value that our products can bring to the lives of our patients. The Allergan team is now 600 strong and has full knowledge and capabilities in pharmaceutical research and development, manufacturing, quality control and market commercialization. We work with over a dozen partners throughout the world for the licensing, manufacturing or development of our marketed and late stage pipeline products.

Allergan Pharmaceuticals has established the goal of becoming the largest privately owned U.S. pharmaceutical company. We are currently working with many of the local universities and discovery centers to identify and keep those innovations in the Atlanta economy through partnerships with Allergan. Our focus is on identifying opportunities that can be brought to the market quickly, with minimal risk and that offer improved outcomes for our patients.

The Allergan Board is comprised of several individuals that have founded, created and led pharmaceutical companies ranging in value from several hundred million to over six billion dollars in market value. Allergan has the management team, products and development projects needed to create the foundation for a strong, sustainable pharmaceutical company that will continually find ways to improve the lives of our patients.

Improving Lives by Advancing Medicine

Allergan Pharmaceuticals is an Atlanta, Georgia based specialty pharmaceutical company which currently markets prescription products for the cardiovascular, hospital and pediatric markets. Allergan also has several branded prescription products in late stage development. In addition, through its Wilshire Division (www.wilshirerx.com) the company markets multiple generic prescription products, has over a dozen ANDAs on file with the FDA and many others in various stages of development.

We believe that our strongest asset is our people and have hired industry veterans with pharmaceutical knowledge and experience across most therapeutic areas in all stages of development, manufacturing and commercialization. We have a strong emphasis on results and believe our differentiation is our speed of execution in decision making and implementation.

Allergan is proud to be a corporate sponsor of a number of nonprofit organizations in our current therapeutic areas. We believe in being a good corporate citizen by doing our part to help associations and foundations that focus on funding discovery of new medicines or helping people afflicted by diseases that our products treat. The entire growing Allergan team is dedicated to creating value for our patients and shareholders by bringing improved medicines to the market with a focus on quality.

Research and Development Product Pipeline

Allergan Pharmaceuticals has multiple projects under various stages of development. These include products in the cardiovascular, hospital, and pediatric and psychiatry areas. We develop both new chemical entities as well as already approved molecules for new indications or in improved dosage forms. Our research scientists have extensive experience in clinical development and work collaboratively with the FDA to obtain market approval. The company has already filed four New Drug Applications (NDAs), three of which have been approved and also has several additional products in late stage development. Link to the Research & Development page to see the projects currently in clinical development.